首页> 外文学位 >Customized contact lens treatments for in-the-eye medication.
【24h】

Customized contact lens treatments for in-the-eye medication.

机译:定制的隐形眼镜治疗眼内药物。

获取原文
获取原文并翻译 | 示例

摘要

Hydrophilic polymer (polymacon, alphafilcon-A) and silicone-based (balafilcon-A) hydrogel contact lenses, before and after surface modification by radio-frequency glow-discharge treatment (RFGDT), were used to monitor methylene blue/silver nitrate drug-surrogate uptake and elution. The drug-loading protocol included ethyl alcohol-swelling delivery into silicone/hydrocarbon compartments and then osmotic delivery into water-dominated compartments. Light and scanning electron microscopy (SEM) were employed to examine the drug-surrogate distributions throughout the lens specimens and revealed a presence of superficial/subsurface deposits of silver and methylene blue. Infrared spectroscopy revealed modified absorption peaks, accordingly. Energy-dispersive x-ray (EDX) analysis and inductively coupled argon plasma atomic emission spectroscopy (ICP) confirmed silver lens depot concentrations and were employed to measured eluate concentrations, while visible spectrophotometry and ICP spectrometry monitored methylene blue and silver elution rates in static versus simulated eye-blinking conditions. Laboratory results confirmed the feasibility of using ethyl alcohol as a potential swelling agent, and the practicality of using RFGDT, SEM, EDX, ICP, and visible spectrophotometry methods as potential analysis instruments for methylene blue and silver concentrations. The differential diffusion rates of drug surrogates from the RFGDT versus as-manufactured silicone-hydrogel (balafilcon-A), alphafilcon-A, and polymacon were compared at each experimental condition using ANOVA statistics. The conclusions reached are that (1) initial drug uptake of surface modified lenses increased in this order: polymacon alphafilcon-A balafilcon-A lenses; (2) drug release rates of the polymacon, and alphafilcon-A remained unaffected by the RFGDT; (3) increased release rates occurred from the RFGDT-surface-modified balafilcon-A lenses; and (4) dynamic forces increased the release rates for all contact lenses.
机译:在通过射频辉光放电处理(RFGDT)进行表面改性之前和之后,使用亲水性聚合物(polymacon,alphafilcon-A)和有机硅类(balafilcon-A)水凝胶隐形眼镜监测亚甲基蓝/硝酸银药物-替代摄取和洗脱。载药方案包括将乙醇溶胀递送至硅酮/碳氢化合物隔室,然后渗透递送至水为主的隔室。使用光镜和扫描电子显微镜(SEM)来检查整个镜片样品中药物替代物的分布,并发现存在银和亚甲蓝的浅表/表面沉积物。红外光谱显示出相应的吸收峰。能量色散X射线(EDX)分析和电感耦合氩等离子体原子发射光谱(ICP)确认了银镜片贮库中的浓度,并用于测量洗脱液浓度,而可见光分光光度法和ICP光谱法则监测了静态与模拟眨眼条件。实验室结果证实了使用乙醇作为潜在的溶胀剂的可行性,以及使用RFGDT,SEM,EDX,ICP和可见分光光度法作为亚甲基蓝和银浓度的潜在分析工具的实用性。使用ANOVA统计数据,比较了每种实验条件下RFGDT与生产的有机硅水凝胶(balafilcon-A),αfilcon-A和polymacon的药物替代物的差异扩散速率。得出的结论是:(1)表面修饰晶状体的初始药物摄取按此顺序增加:聚晶康

著录项

  • 作者

    Fick, James M.;

  • 作者单位

    State University of New York at Buffalo.;

  • 授予单位 State University of New York at Buffalo.;
  • 学科 Engineering Materials Science.; Health Sciences Ophthalmology.
  • 学位 M.S.
  • 年度 2005
  • 页码 171 p.
  • 总页数 171
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 工程材料学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号